Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on rare diseases, has announced its participation in two major healthcare investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference on September 3 at 10:20 a.m. ET and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9 at 3:20 p.m. ET.

Both presentations will be accessible via live audio webcast through the investor relations section of Amicus Therapeutics' corporate website. The company continues its commitment to developing first- and best-in-class medicines for rare diseases.

News Market Reaction – FOLD

-0.78%

-0.78% Session close to close

In the Aug 29 session, FOLD declined 0.78%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September.

• Cantor Global Healthcare Conference 2025 in New York, NY, on Wednesday, September 3, 2025, at 10:20 a.m. ET
• Morgan Stanley 23^rd Annual Global Healthcare Conference 2025 in New York, NY on Tuesday, September 9, 2025, at 3:20 p.m. ET

A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Vice President, Corporate Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When is Amicus Therapeutics (FOLD) presenting at the Cantor Global Healthcare Conference 2025?

Amicus Therapeutics will present at the Cantor Global Healthcare Conference on Wednesday, September 3, 2025, at 10:20 a.m. ET in New York, NY.

What time is FOLD's presentation at the Morgan Stanley Healthcare Conference 2025?

Amicus Therapeutics will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 9, 2025, at 3:20 p.m. ET in New York, NY.

How can investors access Amicus Therapeutics' conference presentations in September 2025?

Investors can access live audio webcasts of both presentations through the investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com/events-and-presentations.

What is Amicus Therapeutics' (FOLD) main business focus?

Amicus Therapeutics is a global biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases.